Editing Biocon

{{short description|Indian biopharmaceutical company}}
{{Use dmy dates|date=October 2023}}

[[File:Biocon_Logo.svg|thumb|right|Biocon Logo]]

'''Biocon Limited''' is an Indian biopharmaceutical company based in [[Bangalore]], [[India]]. Founded in 1978 by [[Kiran Mazumdar-Shaw]], Biocon has grown to become one of the leading biotechnology companies in India, focusing on the development of innovative and affordable biopharmaceuticals.

==History==
Biocon was established in 1978 as a joint venture between Kiran Mazumdar-Shaw and an Irish firm, Biocon Biochemicals Limited. Initially, the company focused on the production of enzymes for the brewing industry. Over the years, Biocon expanded its operations to include the development of biopharmaceuticals, with a focus on [[diabetes]], [[oncology]], and [[autoimmune diseases]].

==Operations==
Biocon operates through its various subsidiaries and divisions, including Biocon Biologics, Syngene International, and Clinigene International. The company is involved in the research, development, and manufacturing of a wide range of products, including [[biosimilars]], [[novel biologics]], and [[generic drugs]].

===Biocon Biologics===
Biocon Biologics is a subsidiary of Biocon Limited, focusing on the development and commercialization of biosimilars. The company has a strong presence in the global biosimilars market, with products approved in over 100 countries.

===Syngene International===
[[File:Bangalore_Biocon.jpg|thumb|left|Biocon's headquarters in Bangalore]]
Syngene International is a contract research organization (CRO) that provides integrated research and development services to global pharmaceutical and biotechnology companies. It offers services in discovery chemistry, discovery biology, and clinical development.

===Clinigene International===
Clinigene International is a clinical research organization (CRO) that provides clinical trial management services. It focuses on conducting clinical trials for new drugs and therapies, ensuring compliance with international regulatory standards.

==Research and Development==
Biocon invests significantly in research and development to drive innovation in biopharmaceuticals. The company's R&D efforts are focused on developing novel biologics and biosimilars for the treatment of chronic diseases such as diabetes, cancer, and autoimmune disorders.

==Biocon Park==
[[File:Biocon_Park_.jpg|thumb|right|Biocon Park]]
Biocon Park is a state-of-the-art integrated research and manufacturing facility located in Bangalore. It is one of the largest biopharmaceutical manufacturing facilities in India, equipped with advanced technology and infrastructure to support the production of biologics and biosimilars.

==Corporate Social Responsibility==
Biocon is committed to corporate social responsibility (CSR) initiatives, focusing on healthcare, education, and environmental sustainability. The Biocon Foundation, the company's CSR arm, implements various programs aimed at improving healthcare access and quality in underserved communities.

==Awards and Recognition==
Biocon has received numerous awards and accolades for its contributions to the biotechnology industry. The company has been recognized for its innovation, leadership, and commitment to social responsibility.

==Related pages==
* [[Kiran Mazumdar-Shaw]]
* [[Biotechnology in India]]
* [[Pharmaceutical industry in India]]

[[Category:Biopharmaceutical companies of India]]
[[Category:Companies based in Bangalore]]
[[Category:Companies established in 1978]]
[[Category:Indian brands]]